Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FBIO

Fortress Biotech (FBIO)

Fortress Biotech Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FBIO
DateTimeSourceHeadlineSymbolCompany
28/01/202500:30GlobeNewswire Inc.Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCTNASDAQ:FBIOFortress Biotech Inc
24/01/202500:30GlobeNewswire Inc.Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of RosaceaNASDAQ:FBIOFortress Biotech Inc
15/01/202500:00GlobeNewswire Inc.Mustang Bio Announces Reverse Stock SplitNASDAQ:FBIOFortress Biotech Inc
07/01/202500:00GlobeNewswire Inc.Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes DiseaseNASDAQ:FBIOFortress Biotech Inc
07/01/202500:00PR Newswire (US)Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) Product Candidate for Treatment of Menkes DiseaseNASDAQ:FBIOFortress Biotech Inc
15/11/202408:10GlobeNewswire Inc.Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
15/11/202408:05GlobeNewswire Inc.Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
13/11/202408:01GlobeNewswire Inc.Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
13/11/202400:30GlobeNewswire Inc.Mustang Bio Receives Positive Listing Determination from NasdaqNASDAQ:FBIOFortress Biotech Inc
08/11/202400:30GlobeNewswire Inc.Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant GliomaNASDAQ:FBIOFortress Biotech Inc
04/11/202423:00GlobeNewswire Inc.Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of RosaceaNASDAQ:FBIOFortress Biotech Inc
25/10/202423:30GlobeNewswire Inc.Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology ConferenceNASDAQ:FBIOFortress Biotech Inc
25/10/202405:10GlobeNewswire Inc.Mustang Bio Announces Exercise of Warrants for $4 Million Gross ProceedsNASDAQ:FBIOFortress Biotech Inc
09/10/202423:30GlobeNewswire Inc.Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual SummitNASDAQ:FBIOFortress Biotech Inc
03/10/202422:30GlobeNewswire Inc.Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities ConferenceNASDAQ:FBIOFortress Biotech Inc
26/09/202422:30GlobeNewswire Inc.Fortress Biotech to Participate in October 2024 Investor ConferencesNASDAQ:FBIOFortress Biotech Inc
20/09/202422:30GlobeNewswire Inc.Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private PlacementsNASDAQ:FBIOFortress Biotech Inc
09/09/202422:30GlobeNewswire Inc.Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) ConferenceNASDAQ:FBIOFortress Biotech Inc
04/09/202422:30GlobeNewswire Inc.Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:FBIOFortress Biotech Inc
04/09/202422:15GlobeNewswire Inc.Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:FBIOFortress Biotech Inc
03/09/202422:30GlobeNewswire Inc.Avenue Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:FBIOFortress Biotech Inc
14/08/202406:05GlobeNewswire Inc.Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
13/08/202406:01GlobeNewswire Inc.Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
10/08/202406:05GlobeNewswire Inc.Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
07/08/202406:01GlobeNewswire Inc.Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024NASDAQ:FBIOFortress Biotech Inc
25/07/202422:30GlobeNewswire Inc.Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027NASDAQ:FBIOFortress Biotech Inc
12/07/202406:05GlobeNewswire Inc.Journey Medical Corporation Appoints Michael C. Pearce to Board of DirectorsNASDAQ:FBIOFortress Biotech Inc
06/07/202406:05GlobeNewswire Inc.Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred StockNASDAQ:FBIOFortress Biotech Inc
22/06/202406:01GlobeNewswire Inc.Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:FBIOFortress Biotech Inc
20/06/202422:30GlobeNewswire Inc.Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceNASDAQ:FBIOFortress Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:FBIO

Your Recent History

Delayed Upgrade Clock